Change begun in 2017 will continue through 2018. 1. appointment of another Director ; 2. exit of existing Chair ; 3. Board elect new Chair ; 4. reappointment of existing M.D. in June ; 5. contract review of CFO November ; 6. contract review of COO ( Jan 2019 ) ; 7. review of General Counsel / joint company secretary contract indicated ; 8. review of joint company secretary contract. Until the identity and background of the new Director is known speculation about who the new Chair is likely to be is based on incomplete information. At the June 249d meeting M.D. said he wanted " a Mandate " for six months and then extended it to twelve months - this was the vote to remove current Chair from Board. Twelve months takes M.D. to June when his contract ends. It seems very unlikely M. D. would choose not to enter a new contract when his work to get new gas flowing in NGP is so close to success. GAP Plan milestones are : A. February drilling ; B. pipeline transportation costs reduction ; C. city gate gas sales prices. Success in all GAP Plan milestones would create a company with different future prospects, different internal organisational skill-set requirements, and substantial,skilled, and continuing focus on shareholder and investment community relations. It seems unlikely the current M.D. would find the situation engaging so the question is how long will his new contract be for / will it be an open ended short-term contract ? Success in all GAP Plan milestones to the extent necessary to make CTP profitable after tax provides CTP with choices and prioritising of nature and timing of future company development. Limited success in any of the GAP Plan milestones renders CTP unviable and some sort of administrative event would be a rational outcome ; in that case all of the anticipated changes in 2018 / 2019 are unproductive events. These are my untutored non-insider thoughts and should not be relied on. DYOR.
- Forums
- ASX - By Stock
- CTP
- 2018 CTP transformation
CTP
central petroleum limited
Add to My Watchlist
1.85%
!
5.5¢

2018 CTP transformation
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.5¢ |
Change
0.001(1.85%) |
Mkt cap ! $40.98M |
Open | High | Low | Value | Volume |
5.4¢ | 5.5¢ | 5.4¢ | $91.62K | 1.696M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 449381 | 5.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.8¢ | 6030 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 449381 | 0.054 |
1 | 100000 | 0.053 |
3 | 719000 | 0.052 |
1 | 800000 | 0.051 |
2 | 39000 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.058 | 6030 | 1 |
0.059 | 379120 | 4 |
0.060 | 160000 | 3 |
0.061 | 100000 | 1 |
0.067 | 149268 | 1 |
Last trade - 15.59pm 27/06/2025 (20 minute delay) ? |
Featured News
CTP (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online